MATSUMOTOKIYOSHI sees its risk increased and a downgrade to Neutral
MATSUMOTOKIYOSHI (JP), a company active in the Drug Retailers industry, increases its market risk and lowers its general evaluation. The independent financial analyst theScreener just requalified the stock market behaviour as moderately risky. On the other hand, theScreener awards a fundamental star to the title, but the new risk assessment downgrades the general evaluation to Neutral. As of the analysis date April 1, 2022, the closing price was JPY 4,320.00 and its expected value was estimated at JPY 4,272.70.Matsumotokiyoshi Holdings is a holding company. Co., through its affiliates, operates in three business segments. The Retail segment is engaged in the sale of drugs and medicines, cosmetics, food, miscellaneous daily goods, commodities and others through nationwide stores. The Wholesale segment provides commodities to its affiliates and franchisee. The Management Support segment is engaged in the construction and repairing of stores, the management of corporate groups and indirect business trust, the non-life and life insurance agency businesses, as well as the distribution of newspaper advertising fliers. As of Mar 31 2017, Co. operates total 1,555 stores throughout Japan.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.